Karyopharm Therapeutics Inc. (KPTI)

$0.74 1.12% $0.00 Healthcare

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1. Its lead compound, include XPOVIO in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma, and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company has license agreement with Menarini Group to develop and commercialize NEXPOVIO for human oncology indications in Europe, including the United Kingdom; Latin America; and other countries. Its oral SINE compounds also designed to force nuclear accumulation in the levels of multiple tumor suppressor and growth regulatory proteins. The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.

$92.85M

Mr. Richard A. Paulson M.B.A.

442.00

Newton, MA

Nov 06, 2013

-0.65

$-1.14

1.47

3.62

-61.72%

-1.01

-0.02

-0.69

0.64

3.56

-42.02%

66.89%

Similar stocks (19)

Agios Pharmaceuticals, Inc.

AGIO

$47.54 4.39%
Uptrend

Replimune Group, Inc.

REPL

$11.42 3.02%
Uptrend

Nuvation Bio Inc.

NUVB

$3.00 3.28%
Neutral

Monte Rosa Therapeutics, Inc.

GLUE

$6.14 3.28%
Neutral

Mersana Therapeutics, Inc.

MRSN

$2.24 5.68%
Downtrend

Gossamer Bio, Inc.

GOSS

$0.94 2.99%
Downtrend

Generation Bio Co.

GBIO

$2.81 8.49%
Downtrend

HOOKIPA Pharma Inc.

HOOK

$4.72 2.08%
Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.60 6.56%
Downtrend

Nuvectis Pharma, Inc.

NVCT

$6.87 2.54%
Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.70 0.07%
Downtrend

Assembly Biosciences, Inc.

ASMB

$18.50 1.82%
Uptrend

bluebird bio, Inc.

BLUE

$0.50 0.20%
Downtrend

CytomX Therapeutics, Inc.

CTMX

$1.22 2.52%
Downtrend

PMV Pharmaceuticals, Inc.

PMVP

$1.54 1.99%
Downtrend

Kronos Bio, Inc.

KRON

$0.95 3.23%
Downtrend

Rallybio Corporation

RLYB

$1.11 0.91%
Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.28 2.29%
Downtrend

Galera Therapeutics, Inc.

GRTX

$0.08 1.89%
Downtrend

ETF Exposure (12)

Invesco NASDAQ Future Gen 200 ETF

QQQS

0.391%

$27.61 2.20%
Uptrend

iShares Micro-Cap ETF

IWC

0.02429%

$126.13 1.86%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.43 -0.28%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.42 -0.28%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.42 -0.26%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$136.02 0.03%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$96.13 -0.25%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$96.11 -0.25%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$134.99 -0.24%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$281.91 1.65%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$134.97 -0.24%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$182.71 1.88%
Uptrend